Related Experiment Video
Updated: Jan 23, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Eliminated patient fee and changes in dispensing patterns of asthma medication in children-An interrupted time series
Elin Dahlén1,2, Joris Komen2,3, Eva W Jonsson4
1Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Insights
Sweden
Area of Science:
- Pediatric Asthma Management
- Health Economics
- Pharmaceutical Policy
Background:
- In 2016, Sweden eliminated patient fees for all prescription drugs for children (0-17 years).
- This policy aimed to improve access to essential medications for pediatric populations.
Purpose of the Study:
- To assess the impact of the fee elimination on asthma medication dispensing patterns in children.
- To analyze changes in prevalence, incidence, volume, and persistence of asthma medication use.
Main Methods:
- An uncontrolled before-and-after study design using dispensing data from Stockholm County (2014-2017).
- Interrupted time series (ITS) analysis was employed to evaluate trends.
- Measures included medication prevalence, incidence, defined daily doses (DDDs), and treatment persistence.
- Socio-economic status was considered using Mosaic data.
Main Results:
- Asthma medication prevalence increased slightly post-intervention, but ITS analysis indicated a pre-existing upward trend.
- A statistically significant increase in dispensed medication volume (DDDs/child/month) was observed post-intervention.
- Treatment persistence for asthma medications rose, particularly among children with lower socio-economic status.
Conclusions:
- The elimination of patient fees had a modest association with changes in pediatric asthma medication dispensing.
- A slight increase in dispensed medication volume was noted, with a more pronounced effect in lower socio-economic groups.
- Policy changes may influence medication access and adherence, especially in vulnerable pediatric populations.
Abstract:
In 2016, all prescription drugs included in the reimbursement system in Sweden were made available for children (age 0-17 years) without any patient fees. Our aim was to estimate the association between this intervention and the dispensing patterns of asthma medications among children. Dispensing data on asthma medications for all children living in Stockholm County during 2014-2017 were selected to include two years before (January 2014-December 2015) and after (January 2016-December 2017) the intervention. In an uncontrolled before and after study, the measures of utilization were as follows: the proportion of children with at least one dispensed asthma medication (prevalence); the number of children initiated on treatment after an 18-month drug-free period (incidence); the number of defined daily doses (DDDs) dispensed per child; and the number of children with at least two prescriptions with controller medication (inhaled corticosteroid or leukotriene receptor antagonist) dispensed during 18 months (persistence). In an interrupted time series (ITS) analysis, all measures were included except for persistence. Socio-economic status was defined using Mosaic data. The prevalence increased after the intervention (from 11.9% to 13.0%). However, the ITS analysis showed a positive trend already before the intervention, and consequently, the increase was not attributable to the intervention. For incidence, similar patterns were observed. There was an increase in dispensed volumes related to the intervention, 46.3 DDDs/child/month before and 51.1 after the intervention (P-value 0.01). The proportion of children with persistent asthma medication increased from 46.0% to 51.9% in children with low socio-economic status. In conclusion, the intervention was only modestly associated with changes in the dispensing patterns of asthma medication, with the volume dispensed per child increasing slightly, particularly in children with low socio-economic status.
Related Concept Videos
Time-Series Graph
Discrete-Time Fourier Series
For a discrete-time periodic signal x[n]...
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications
Classification of Asthma

